- ROUNDTABLE: Pharmacy’s future in sync with technology
- CVS Caremark study: More education needed on genetic testing in prescribing antiplatelet drugs
- Harvard Heart Letter: Many consumers who supplement with aspirin don't need to
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- Dr. Reddy's launches moxifloxacin tablets
HYDERABAD, India — Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.
The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension. The tablets are being launched in the 500-mg and 875-mg strengths, while the capsules are in the 250-mg and 500-mg strengths, and the oral suspension is in the 125-mg-, 200-mg-, 250-mg- and 400-mg-per-5-mL strengths.
The drug is a generic version of GlaxoSmithKline's Amoxil. For the 12-month period ended in June, branded and generic versions of the drug had sales of $22.2 million for the tablets, $67.2 million for the capsules and $89.5 million for the oral suspension, according to IMS Health.